Taro Pharmaceutical Industries Ltd (TARO) Inventory Turnover Ratio, from fourth quarter 2023 to fourth quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Taro Pharmaceutical Industries Ltd  (NYSE: TARO)
 

Taro Pharmaceutical Industries Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Taro Pharmaceutical Industries Ltd's inventory turnover ratio, the ratio that measures Taro Pharmaceutical Industries Ltd's ability to manage its supply chain, sequentially decreased to 1.53 in the fourth quarter 2023, which does not come as a surprise, as the Taro Pharmaceutical Industries Ltd continue to experience headwinds, which also impact its supply chain. Taro Pharmaceutical Industries Ltd's average inventory processing period in the Mar 31 2023 quarter, has increased to 239 days, from 231 days, in the 0 quarter.

Within Healthcare sector 299 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2023, to 1796, from total ranking in the third quarter 2023 at 1878.

TARO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Taro Pharmaceutical Industries Ltd Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TARO Inventory Turnover Ratio (Mar 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Inventory Growth 114.1 % 25.72 % 25.72 % -34.56 % 23.17 %
Y / Y Cost of Sales Growth 13.58 % - - - 6.3 %
Inventory Turnover Ratio (TTM) 1.53 - - - 1.66
TARO's Total Ranking # 1796 # 1878 # 1879 # 1826 # 1889
Average inventory processing period 239 - - - 220
Seq. Inventory Growth 0 % 0 % 92.11 % 11.45 % -41.28 %
Seq. Cost of Sales Growth - - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 89
Healthcare Sector # 300
Overall Market # 1796

Inventory Turnover Ratio Statistics
High Average Low
1.87 1.69 1.43
(Mar 31 2020)   (Mar 31 2016)



TARO Company Profile >> Back to TARO Efficiency Comparisons >> Compare TARO Inventory Turnover Ratio to its Competitors

Financial Statements
Taro Pharmaceutical Industries Ltd's Inventories $ 227 Millions Visit TARO's Balance sheet
Taro Pharmaceutical Industries Ltd's Cost of Revenues TTM $ 305 Millions Visit TARO's Income Statement
What are TARO's Sales? Visit TARO's Sales by Segment

Other Inventory Turnover Ratios
Taro Pharmaceutical Industries Ltd's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TARO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TARO's Competitors
Inventory Turnover Ratio for TARO's Suppliers
Inventory Turnover Ratio for TARO's Customers

You may also want to know
TARO's Sales Growth Rates TARO's Pe Price to earnings ratio TARO's Receivables Turnover Ratio TARO's Stock Quote
TARO's Net Income Growth Rates TARO's Ps Price to Sales ratio TARO's Sales per Employee TARO's Asset Turnover Ratio
TARO's Net Margin TARO's Pb Price to Book ratio TARO's Financial Strength Ratios TARO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2023 Inventories at quarter ending Mar 31 2023
Mimedx Group Inc   3.68 $ 50.799  Millions$ 14  Millions
Moderna Inc   3.66 $ 5,191.000  Millions$ 1,420  Millions
Logicmark Inc  3.66 $ 4.186  Millions$ 1  Millions
Nexgel Inc   3.65 $ 2.051  Millions$ 1  Millions
Myomo Inc   3.61 $ 5.151  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  3.60 $ 63.398  Millions$ 18  Millions
Tandem Diabetes Care Inc   3.58 $ 389.893  Millions$ 109  Millions
Bausch Health Companies Inc   3.54 $ 2,365.000  Millions$ 667  Millions
Orasure Technologies Inc  3.53 $ 285.555  Millions$ 81  Millions
Vericel Corporation  3.53 $ 56.452  Millions$ 16  Millions
Baxter International Inc   3.52 $ 9,659.000  Millions$ 2,745  Millions
Align Technology inc   3.49 $ 1,119.480  Millions$ 320  Millions
3m Company  3.47 $ 19,019.000  Millions$ 5,485  Millions
Tactile Systems Technology Inc   3.44 $ 74.071  Millions$ 22  Millions
Ainos Inc   3.43 $ 2.174  Millions$ 1  Millions
Electromed Inc   3.42 $ 11.537  Millions$ 3  Millions
Prestige Consumer Healthcare Inc   3.38 $ 502.431  Millions$ 149  Millions
Ginkgo Bioworks Holdings Inc   3.28 $ 17.092  Millions$ 5  Millions
Aytu Biopharma Inc  3.28 $ 41.205  Millions$ 13  Millions
Aquestive Therapeutics Inc   3.25 $ 19.909  Millions$ 6  Millions
Dexcom Inc   3.25 $ 1,074.900  Millions$ 331  Millions
Dynavax Technologies Corporation  3.23 $ 236.903  Millions$ 73  Millions
Twist Bioscience Corporation  3.20 $ 133.671  Millions$ 42  Millions
Zeo Scientifix Inc   3.17 $ 0.690  Millions$ 0  Millions
Waters Corporation  3.11 $ 1,246.877  Millions$ 401  Millions
Smiledirectclub Inc   3.09 $ 132.716  Millions$ 43  Millions
Sonoma Pharmaceuticals Inc   3.05 $ 8.795  Millions$ 3  Millions
Pfizer Inc  3.04 $ 29,246.000  Millions$ 9,622  Millions
Sunshine Biopharma Inc   3.03 $ 5.655  Millions$ 2  Millions
Abbott Laboratories  3.02 $ 18,486.000  Millions$ 6,120  Millions

Date modified: 2023-06-30T08:25:33+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.